The article explores the personal experiences of individuals using the weight-loss drug Wegovy, revealing the nuanced realities of weight management. Despite being on the medication for several months, the author mentions no significant weight loss, though their overall health perspective is broader than simple numerical value. Wegovy belongs to a group of medications called semaglutides, which work by acting as GLP-1 agonists, enhancing the body's natural regulatory systems for digestion. The emphasis is on understanding the complexity of weight loss journeys and individual responses to medication.
If I went just by the number on the scale to assess my state of being, the drug has failed me and this has all been a waste of time.
Wegovy belongs to a new class of weight-loss drugs known as semaglutides, with Ozempic being the most well-known brand in that class.
These drugs are known as GLP-1 agonists. GLP-1 is a naturally occurring hormone that works with your brain to control digestion.
It's important for people starting weight-loss medications to understand that the journey is not just about the number on the scale.
Collection
[
|
...
]